Associate Professor Xianqin Qu

Phone: +61 2 9514 7852

Fax: +61 2 9514 8206

Xianqin.Qu@uts.edu.au

Academic Qualifications

• Bachelor of Chinese Medicine (Beijing)
• Master of Cardiovasular Medicine (Beijing)
• PhD in Clinical Pharmacology (Sydney)

Teaching Activities

• Pharmacology of Chinese Herbal Medicine
• Clinical subjects of Chinese Medicine
• Supervising Masters and senior undergraduate students' practice of Chinese herbal medicine

Research Interests and Activities

• Chinese herbal medicines, metabolic syndrome and type 2 diabetes: evaluating the effects and mechanism of herbal extracts in rodent models of genetically and dietary factor-induced obesity and type 2 diabetes, developing anti-hyperlipidaemic, anti-obesity and anti-diabetic herbal products.

• Molecular approach to insulin resistance in obesity and type 2 diabetes: investigating the effects of antisense RNA oligonucleotides which are targeted at adipokines on insulin resistance and obesity.

Research topics for Honours and Postgraduate Students

• How does Fu Tang Ping (an herbal product) improve glycaemic control?

• Targeting retinal bonding 4 protein and chemoattractant protein-1 genes using antisense RNA oligonucleotides to manage insulin resistance and obesity.

Research student

• Ms Yi Tan: Master Candidate since 2005

Selected publications

• Donnelly R, Wang B, Qu X (2006). Type 2 diabetes in China: partnerships in education and research to evaluate new antidiabetic treatments. Br. J Pharmacol. 61:702-705.

• Dang L, Seale JP, Qu X (2005). Protein Kinase C activation induced by high glucose concentration mediates human umbilical vein endothelial cell permeability independent on calcium-nitric oxide signalling pathway. Clin. Exp. Pharmacol. Physio. 32: 771-776.

• Samuel V. Lui ZX, Qu X, Yu CL, Chen Y, Zong H & Shulman GI (2004). Mechanism of insulin resistance in Non-alcoholic fatty liver disease. J Biol Chem 279: 32345-53.

• Dang L, Seale JP, Qu X (2004). Reduction of high glucose and phorbol-myristate-acetate-induced endothelial cell permeability by protein kinase C inhibitors LY379196 and hypocrellin A. Biochem. Pharmacol. 67: 855-864.